PR Newswire
Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
📈
AI Sentiment
Highly Positive
8/10
Lipocine Inc. News
Latest updates and market news for LPCN
1 news
Jan 16 - Jan 22, 2026
Page 1
Share this news page